RPG Investment Advisory LLC Invests $269,000 in Sabra Healthcare REIT, Inc. $SBRA

Key Points

• RPG Investment Advisory LLC acquired 15,408 shares of Sabra Healthcare REIT valued at approximately $269,000 during the first quarter, highlighting continued interest from institutional investors.
• Sabra Healthcare REIT reported a better-than-expected EPS of $0.38 for the last quarter, surpassing analysts' estimates, and set its FY 2025 guidance at 1.450-1.470 EPS.
• The company announced a quarterly dividend of $0.30, representing a 6.1% yield, with a payout ratio currently at 157.89%.

RPG Investment Advisory LLC bought a new position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 15,408 shares of the real estate investment trust's stock, valued at approximately $269,000.

Other hedge funds have also recently modified their holdings of the company. UMB Bank n.a. lifted its holdings in shares of Sabra Healthcare REIT by 379.6% in the first quarter. UMB Bank n.a. now owns 2,048 shares of the real estate investment trust's stock worth $36,000 after buying an additional 1,621 shares in the last quarter. Assetmark Inc. lifted its holdings in shares of Sabra Healthcare REIT by 37.8% in the first quarter. Assetmark Inc. now owns 3,607 shares of the real estate investment trust's stock worth $63,000 after buying an additional 989 shares in the last quarter. BI Asset Management Fondsmaeglerselskab A S purchased a new position in shares of Sabra Healthcare REIT in the first quarter worth $63,000. Fifth Third Bancorp lifted its holdings in shares of Sabra Healthcare REIT by 110.3% in the first quarter. Fifth Third Bancorp now owns 3,835 shares of the real estate investment trust's stock worth $67,000 after buying an additional 2,011 shares in the last quarter. Finally, GF Fund Management CO. LTD. purchased a new position in shares of Sabra Healthcare REIT in the fourth quarter worth $74,000. Hedge funds and other institutional investors own 99.40% of the company's stock.

Sabra Healthcare REIT Trading Up 1.6%

SBRA stock traded up $0.31 during mid-day trading on Wednesday, reaching $19.50. 567,010 shares of the stock traded hands, compared to its average volume of 2,450,267. The company has a debt-to-equity ratio of 0.91, a quick ratio of 4.80 and a current ratio of 4.80. Sabra Healthcare REIT, Inc. has a one year low of $15.60 and a one year high of $20.03. The stock has a market capitalization of $4.67 billion, a PE ratio of 25.64, a PEG ratio of 1.53 and a beta of 0.86. The business has a 50-day moving average price of $18.49 and a two-hundred day moving average price of $17.73.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last posted its quarterly earnings data on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share for the quarter, beating analysts' consensus estimates of $0.36 by $0.02. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The business had revenue of $189.15 million for the quarter, compared to analysts' expectations of $185.64 million. During the same quarter in the previous year, the business posted $0.36 earnings per share. The business's revenue was up 7.4% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. Equities research analysts expect that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current year.

Sabra Healthcare REIT Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, August 29th. Stockholders of record on Friday, August 15th will be issued a $0.30 dividend. The ex-dividend date is Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.2%. Sabra Healthcare REIT's dividend payout ratio is presently 157.89%.

Analyst Ratings Changes

Several equities analysts have recently commented on SBRA shares. BMO Capital Markets boosted their target price on shares of Sabra Healthcare REIT from $19.00 to $22.00 and gave the stock a "market perform" rating in a report on Monday. Scotiabank upped their price target on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a research note on Monday, June 23rd. Wells Fargo & Company upped their price target on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an "overweight" rating in a research note on Wednesday. Finally, JMP Securities upped their price target on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a "market outperform" rating in a research note on Wednesday, August 6th. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and four have assigned a Hold rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $20.43.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.